Tivic Health Systems, Inc. Stock Price

NasdaqCM:TIVC Community·US$2.9m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

TIVC Share Price Performance

US$1.00

-3.47 (-77.63%)

US$1.00

-3.47 (-77.63%)

US$1.00

Sat, 4 Apr 26

Share Pricen/a

TIVC Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Excellent balance sheet with moderate risk.

5 Risks

0 Rewards

View Full Analysis

Tivic Health Systems, Inc. Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

n/a

: -2.78
: 0%
: 0%
: 38.4%

View Full Analysis

About TIVC

Founded: 2016
Employees: 7
CEO: Michael Handley
WebsiteView website: tivichealth.com

Tivic Health Systems, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company’s pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was incorporated in 2016 and is based in San Antonio, Texas.